host
respons
contribut
sever
viral
infect
failur
innat
antivir
mechan
recogn
restrict
pathogen
develop
intens
system
inflamm
lead
circulatori
failur
tissu
injuri
result
overli
exuber
cellmedi
immun
respons
highthroughput
genom
method
use
identifi
biochem
pathway
underli
ineffect
damag
host
respons
number
acut
chronic
viral
infect
articl
review
recent
geneexpress
studi
influenza
ebola
hemorrhag
fever
cell
cultur
anim
model
focus
genom
experi
use
increas
understand
mechan
permit
virus
caus
rapidli
overwhelm
infect
particular
attent
paid
evas
type
ifn
respons
infect
cell
might
contribut
overactiv
inflammatori
respons
review
recent
research
describ
futur
studi
might
tailor
understand
relationship
infect
cell
environ
articl
discuss
rapidli
grow
field
highthroughput
genom
contribut
complet
understand
sever
acut
viral
infect
identifi
novel
target
therapeut
intervent
develop
express
microarray
highthroughput
genom
proteom
techniqu
promis
unravel
mani
complex
hostpathogen
interact
fornek
et
al
geiss
et
al
jenner
young
korth
et
al
liu
et
al
although
virus
employ
divers
strategi
control
host
cellular
process
posttranscript
level
regul
gene
express
central
virushost
relationship
kash
et
al
messeng
rna
express
microarray
method
allow
simultan
measur
ten
thousand
gene
greatli
increas
abil
document
character
key
interact
regul
host
gene
express
especi
import
rna
virus
limit
number
enzymat
activ
encod
genom
therefor
requir
facilit
host
environ
effici
replic
rna
virus
thu
need
regul
host
gene
express
environ
ensur
adequ
suppli
metabolit
rna
protein
lipid
biosynthesi
product
new
virion
time
suppress
antivir
cellular
defens
respons
pathway
prevent
detect
clearanc
immun
system
primari
import
rna
viru
replic
antagon
broad
spectrum
antivir
activ
associ
activ
doubl
strand
rna
dsrna
type
interferon
ifn
respons
review
garciasastr
biron
loo
gale
randal
goodbourn
sadler
william
howev
overstrong
viral
antagon
andor
evas
dsrnaifn
respons
lead
high
rate
viral
replic
signific
inflamm
sever
diseas
patholog
especi
true
highli
virul
rna
virus
ebola
pandem
influenza
bray
garciasastr
garciasastr
garciasastr
harcourt
et
al
villing
et
al
convent
antivir
therapi
typic
design
directli
inhibit
viral
replic
target
enzymat
activ
viral
protein
howev
given
abil
rna
virus
rapidli
mutat
countermeasur
often
lead
develop
drug
resist
one
approach
help
mitig
impact
mutat
addit
target
host
respons
reduc
pathogenesi
multitarget
therapi
design
limit
viral
replic
mitig
immunopatholog
promis
greatli
increas
capac
combat
viral
diseas
improv
human
health
highli
virul
virus
dysregul
immun
respons
manner
treatment
modal
might
develop
target
host
respons
pathway
common
mani
virus
moreov
drug
modul
inflammatori
respons
could
use
earli
critic
care
set
accur
diagnosi
made
virusspecif
antivir
drug
administ
although
express
microarray
experi
use
studi
host
respons
mani
differ
rna
virus
includ
sarscov
baa
et
al
cameron
et
al
de
lang
et
al
reghunathan
et
al
dengu
fink
et
al
ubol
et
al
wark
et
al
west
nile
fredericksen
et
al
venter
et
al
hepat
c
virus
walter
katz
articl
focu
applic
genom
technolog
studi
differ
aspect
highli
pathogen
influenza
ebola
viru
infect
cell
cultur
anim
model
influenza
ebola
virus
exampl
rna
virus
caus
rapidli
progress
fulmin
infect
mark
activ
inflammatori
respons
moreov
also
signific
human
pathogen
epidem
pandem
potenti
import
area
antivir
drug
research
character
virus
alter
gene
express
vitro
vivo
provid
complementari
perspect
rna
virushost
relationship
cell
cultur
model
critic
understand
might
term
replic
compon
infecti
diseas
afford
opportun
studi
primari
respons
host
cell
absenc
immun
cell
inflammatori
respons
contrast
studi
anim
model
use
investig
might
call
diseas
compon
infect
reveal
whole
infect
process
includ
immun
cellmedi
effect
thu
combin
advantag
greater
control
experiment
variabl
vitro
biolog
relev
complex
vivo
model
studi
global
host
respons
use
function
genom
promis
expand
develop
new
antivir
drug
target
host
immun
respons
therapeut
intervent
articl
aim
present
comprehens
review
microarray
studi
rna
viral
infect
describ
function
genom
technolog
increas
understand
sever
acut
viral
infect
vitro
vivo
use
influenza
ebola
virus
exampl
approach
develop
promot
identif
novel
multitarget
antivir
therapi
also
discuss
key
requir
success
protect
viral
infect
earli
detect
viral
biomolecul
activ
host
respons
limit
replic
activ
immun
respons
central
earli
warn
system
pathogen
associ
molecular
pattern
pamp
receptor
saito
gale
includ
multipl
famili
protein
sampl
extracellular
intracellular
environ
divers
biomolecul
includ
lipoprotein
dna
rna
second
cornerston
effect
antivir
respons
rapid
trigger
broad
spectrum
antivir
activ
pamp
receptor
type
ifn
respons
type
ifn
refer
larg
famili
protein
compos
seven
class
includ
distinct
gene
gene
pestka
et
al
human
encod
mani
distinct
type
ifn
unknown
gener
domin
antivir
ifn
produc
cell
expos
viral
infect
dsrna
trigger
express
interferon
stimul
gene
isg
borden
et
al
altern
activ
pathway
express
isg
mediat
type
iii
ifn
ifnl
signal
heterodimer
activ
isg
express
review
ank
et
al
type
iii
ifn
recent
shown
import
compon
antivir
respons
epitheli
cell
particip
host
respons
influenza
viru
infect
ank
et
al
kotenko
et
al
mordstein
et
al
onoguchi
et
al
osterlund
et
al
sommereyn
et
al
present
number
isg
activ
stimul
type
ifn
receptor
thought
approxim
uniqu
gene
interestingli
mechan
action
hand
key
antivir
protein
current
understood
replic
rna
virus
result
synthesi
dsrna
molecul
detect
pamp
receptor
includ
rigi
pkr
balachandran
barber
takeuchi
akira
recent
erassoci
transmembran
pamp
receptor
call
sting
stimul
interferon
gene
identifi
shown
play
import
role
innat
antivir
respons
ishikawa
barber
activ
pamp
receptor
viral
rna
lead
rapid
activ
transcript
factor
includ
synthesi
type
ifn
protein
subsequ
express
isg
saito
gale
potent
antivir
defens
properti
ifn
respons
rna
virus
evolv
divers
strategi
either
prevent
activ
pamp
receptor
inhibit
signal
ifn
receptor
limit
isg
express
evad
isg
antivir
activ
garciasastr
biron
exampl
influenza
viru
protein
sever
describ
activ
includ
antagon
rigi
pkr
inhibit
antivir
respons
premrna
process
translat
hale
et
al
kash
et
al
ebola
virus
similarli
encod
protein
greatli
limit
host
cell
ifn
respons
includ
inhibit
ifn
respons
activ
protein
basler
et
al
basler
et
al
enterlein
et
al
hartman
et
al
hartman
et
al
reid
et
al
follow
section
present
recent
exampl
applic
function
genom
approach
studi
highli
pathogen
influenza
ebola
viru
infect
show
global
relationship
regul
type
ifn
respons
viral
replic
pathogenesi
viral
diseas
outcom
express
function
genom
studi
develop
provid
detail
knowledg
contribut
aberr
immun
respons
activ
develop
sever
patholog
also
discuss
elucid
underli
molecular
mechan
pathogenesi
identifi
common
host
pathway
differ
viral
infect
goal
experiment
approach
identifi
novel
host
target
broadspectrum
antivir
therapi
reduc
diseas
sever
improv
human
health
influenza
virus
member
orthomyxovirida
famili
neg
sens
segment
rna
virus
replic
primarili
epitheli
cell
upper
lower
respiratori
tract
also
shown
replic
alveolar
macrophag
human
suarez
et
al
van
campen
et
al
influenza
viru
respons
approxim
death
unit
state
annual
period
epidem
pandem
caus
significantli
higher
mortal
thompson
et
al
influenza
pandem
known
spanish
influenza
respons
estim
million
death
worldwid
approxim
death
unit
state
taubenberg
taubenberg
et
al
histolog
analysi
autopsi
sampl
human
influenza
case
shown
death
associ
signific
damag
lung
acut
focal
bronchiti
alveol
human
case
also
show
influenza
viral
pneumonia
associ
massiv
pulmonari
edema
hemorrhag
destruct
respiratori
epithelium
major
case
examin
also
associ
sever
secondari
bacteri
pneumonia
recent
highli
pathogen
virus
emerg
human
pathogen
high
case
fatal
rate
base
evid
cytokin
storm
may
contribut
lethal
infect
hypothes
sever
influenza
viral
pneumonia
could
result
similarli
exagger
inflammatori
respons
renew
threat
modern
pandem
catastroph
health
econom
consequ
understand
contribut
host
immun
respons
sever
influenza
viru
infect
essenti
develop
new
prognost
indic
treatment
modal
howev
contribut
viral
host
inflammatori
respons
develop
sever
lung
patholog
diseas
caus
influenza
viru
unknown
viru
could
reconstruct
studi
reconstruct
influenza
viru
accomplish
gene
influenza
viru
sequenc
lung
tissu
collect
human
fatal
pandem
basler
et
al
reid
et
al
reid
et
al
reid
et
al
reid
et
al
taubenberg
et
al
taubenberg
et
al
tumpey
et
al
sequenc
analysi
suggest
pandem
viru
like
direct
introduct
avian
viru
human
influenza
viru
construct
use
revers
genet
initi
experi
show
reconstruct
viru
replic
high
titer
cell
cultur
lethal
mice
embryon
chicken
egg
tumpey
et
al
studi
activ
host
respons
viru
infect
infect
balbc
mice
season
human
viru
compar
infect
reconstruct
influenza
viru
kash
et
al
lung
infect
mice
analyz
viral
replic
plaqu
assay
patholog
hematoxylin
eosin
h
e
stain
host
respons
determin
express
microarray
quantit
realtim
pcr
elisa
key
immun
mediat
goal
experi
determin
relationship
sever
patholog
induc
infect
activ
host
immun
respons
help
understand
influenza
pandem
sever
mice
infect
viru
minim
mild
diffus
histiocyt
alveol
without
neutrophil
lesion
bronchi
bronchiol
contrast
mice
infect
show
rapid
sever
weight
loss
high
level
viral
replic
lung
death
day
postinfect
pi
lung
anim
display
sever
pulmonari
lesion
sever
necrot
bronchiti
accompani
sever
alveol
edema
contrast
mice
infect
show
minim
weight
loss
significantli
lower
viral
replic
studi
activ
host
respons
infect
express
microarray
analysi
perform
compar
equal
mass
total
rna
isol
lung
mice
infect
influenza
virus
common
refer
sampl
prepar
lung
mockinfect
mice
kash
et
al
bioinformat
analysi
microarray
data
show
infect
result
host
gene
express
respons
limit
intens
durat
mirror
kinet
viral
replic
patholog
interestingli
lung
infect
mice
also
show
activ
cell
cycl
glutathion
metabol
atp
gener
relat
gene
observ
suggest
activ
metabol
pathway
could
import
prevent
damag
reactiv
oxygen
speci
stimul
tissu
remodel
contrast
viru
infect
result
signific
increas
express
inflammatori
respons
gene
ifngamma
tnfalpha
addit
gene
associ
activ
immun
cell
popul
viru
infect
includ
cell
nk
cell
macrophag
neutrophil
gene
express
chang
persist
intens
death
day
pi
mirror
sever
lung
patholog
addit
viru
infect
result
mark
activ
mani
cell
deathrel
gene
particularli
relat
death
receptor
respons
includ
trail
fa
result
suggest
inflammatori
reactiv
oxygen
speci
gener
activ
cell
death
respons
might
import
contributor
sever
immunopatholog
associ
influenza
viru
infect
experiment
approach
also
use
studi
differ
combin
gene
contribut
virul
kash
et
al
kash
et
al
exampl
mice
addit
infect
chimer
viru
contain
ha
na
gene
ha
na
np
ns
gene
although
three
virus
caus
lethal
infect
mice
infect
show
sever
weight
loss
lung
patholog
earliest
mean
time
death
rapid
peak
viral
replic
shown
fig
mice
infect
virus
display
continuum
mild
sever
necrot
bronchiti
accompani
moder
sever
alveol
alveolar
edema
charact
alveol
also
vari
chimer
fulli
reconstruct
virus
day
infect
mice
display
acut
moder
sever
diffus
alveol
promin
neutrophil
compon
sever
alveolar
edema
observ
virus
also
shown
fig
express
pattern
cytokin
chemokin
cell
deathrel
gene
parallel
patholog
find
show
signific
earliest
activ
occur
infect
infect
induc
signific
express
immun
respons
gene
occur
earli
persist
death
day
infect
result
limit
express
gene
intens
durat
moreov
appear
magnitud
upregul
immunerel
mrna
could
correl
virul
viru
induc
highest
earliest
express
gene
follow
magnitud
occurr
moreov
pathway
analysi
express
array
data
reveal
infect
viru
result
signific
activ
death
receptor
tolllik
receptor
type
interferon
respons
previou
studi
shown
protein
potent
antagonist
type
ifn
respons
geiss
et
al
thu
surpris
signific
induct
type
ifn
respons
observ
shown
fig
robust
express
ifn
regul
gene
lung
infect
mice
howev
fail
inhibit
viral
replic
unabl
protect
host
effect
influenza
viru
infect
hypothes
increas
antivir
respons
gene
express
associ
increas
viral
replic
might
explain
heterogen
cell
type
infect
statu
cell
present
lung
ii
small
percentag
cell
suscept
sustain
influenza
viru
infect
iii
signific
part
host
respons
gene
express
would
deriv
signific
infiltr
activ
immun
cell
taken
togeth
result
suggest
overactiv
inflammatori
respons
may
contribut
sever
highli
pathogen
influenza
viru
infect
also
protect
cell
damag
immun
cell
hypercytokinemia
oxygen
radic
may
limit
tissu
destruct
facilit
repair
howev
experi
perform
intact
lung
tissu
gene
express
pattern
repres
averag
gene
express
cell
lung
tissu
includ
larg
number
infiltr
immun
cell
thu
clearli
understand
relationship
viral
regul
antivir
gene
influenza
viru
virul
studi
infect
tissu
isol
infect
anim
tissu
dissect
could
use
deconvolut
gene
express
pattern
limit
cell
heterogen
would
need
primat
modelin
complementari
studi
respons
cynomolgu
macaqu
macaca
fasciculari
infect
influenza
viru
compar
infect
season
humanadapt
influenza
viru
kobasa
et
al
infect
macaqu
influenza
result
uniformli
lethal
sever
viral
pneumonia
infect
anim
develop
greatli
reduc
symptom
patholog
surviv
studi
activ
antivir
respons
viru
infect
bronchu
tissu
chosen
express
microarray
analysi
allow
comparison
host
respons
bronchial
epitheli
cell
primari
target
cell
influenza
viru
replic
reduc
confound
effect
signific
immun
cell
deriv
gene
express
compar
studi
intact
lung
microarray
analysi
perform
bronchu
tissu
isol
infect
anim
show
signific
differ
intens
durat
antivir
host
respons
gene
express
pattern
shown
fig
observ
infect
viru
induc
signific
antivir
respons
particularli
signific
express
type
ifn
relat
gene
includ
mani
type
ifn
correl
peak
viral
load
pfug
tissu
day
subsequ
repress
viru
longer
detect
day
kobasa
et
al
contrast
microarray
analysi
bronchu
tissu
isol
viru
infect
macaqu
show
littl
express
gene
observ
infect
tissu
also
reveal
sustain
mildli
reduc
activ
type
ifn
relat
gene
express
compar
though
viral
load
approxim
time
higher
interestingli
infect
sampl
show
significantli
elev
express
proinflammatori
cytokin
chemokin
includ
neutrophil
chemoattract
result
indic
influenza
viru
abl
significantli
suppress
express
least
type
ifn
gene
impair
protect
host
respons
infect
observ
infect
anim
induc
express
neutrophil
chemokin
thu
signific
viral
antagon
type
ifn
respons
activ
chemokin
express
appear
critic
compon
influenza
viru
virul
lead
high
replic
rate
signific
recruit
inflammatori
cell
sever
lung
patholog
thu
focus
upper
respiratori
parenchym
cell
studi
express
microarray
import
insight
viral
control
antivir
ifnrel
respons
influenza
viru
vivo
could
made
advantag
util
approach
minim
cell
heterogen
preserv
benefit
studi
infect
anim
discuss
detail
later
highli
pathogen
virus
southeast
asia
recent
emerg
virus
caus
rare
rapidli
fatal
diseas
human
mortal
rate
exceed
percent
abdelghafar
et
al
claa
et
al
de
wit
fouchier
studi
similarli
demonstr
virus
also
caus
rapid
lethal
diseas
mani
anim
model
includ
mice
ferret
gao
et
al
gubareva
et
al
lu
et
al
suarez
et
al
subbarao
et
al
similar
experi
influenza
viru
mous
lung
david
kelvin
group
recent
use
function
genom
show
mark
activ
type
ifn
respons
associ
highli
virul
influenza
viru
infect
ferret
lung
cameron
et
al
particular
studi
show
robust
lung
express
ifn
regul
gene
cognat
receptor
kelvin
group
use
observ
genom
data
perform
addit
studi
treat
infect
ferret
antagonist
amgen
quantifi
role
type
ifn
regul
pathway
treatment
infect
ferret
reduc
diseas
sever
delay
mortal
infect
ferret
show
unregul
ifn
respons
least
partial
respons
diseas
sever
model
studi
illustr
potenti
function
genom
identifi
host
pathway
may
overactiv
highli
virul
infect
current
antivir
alreadi
develop
provid
opportun
character
relationship
activ
inflammatori
respons
lung
infect
anim
genom
studi
reli
whole
lung
tissu
heavili
influenc
cell
type
heterogen
immun
cell
infiltr
infect
statu
temptat
tri
understand
microarray
data
perspect
infect
cell
howev
fundament
incorrect
microarray
experi
perform
rna
isol
infect
lung
tissu
result
give
averag
gene
express
cell
entir
tissu
thu
end
left
lack
detail
knowledg
contribut
individu
cell
type
infect
uninfect
make
aggreg
gene
express
chang
identifi
intact
lung
howev
experi
rais
excit
fundament
new
question
studi
normal
human
lung
shown
least
five
major
cell
type
present
parenchyma
cell
includ
type
ii
alveolar
epitheli
capillari
epitheli
interstiti
cell
rang
alveolar
macrophag
crapo
et
al
cell
type
heterogen
complic
influenza
viru
infect
result
signific
infiltr
numer
activ
immun
cell
includ
macrophag
neutrophil
nk
cell
b
lymphocyt
perron
et
al
ad
complex
approxim
lung
cell
ie
respiratori
epitheli
cell
alveolar
macrophag
suscept
primari
influenza
viru
infect
therefor
contribut
influenza
viral
replic
respiratori
epithelium
overal
transcript
profil
whole
infect
lung
imposs
determin
use
intact
tissu
model
thu
reduc
cellular
heterogen
experiment
anim
human
deriv
sampl
import
goal
understand
viral
diseas
biolog
relev
model
system
one
simpl
approach
focu
close
infect
cell
type
uninfect
bystand
cell
use
tradit
surgic
dissect
isol
distinct
region
infect
tissu
organ
perform
viru
macaqu
studi
howev
difficult
small
anim
model
mice
allow
discrimin
respons
infect
bystand
cell
anoth
approach
reduc
confound
effect
cell
heterogen
isol
studi
individu
live
cell
popul
use
flow
cytometri
fluoresc
activ
cell
sort
fac
similarli
laser
captur
microdissect
lcm
fix
sampl
could
use
isol
specif
cell
popul
determin
gene
express
profil
infect
cell
cell
adjac
infect
andor
inflammatori
cell
isol
approach
would
requir
studi
effect
infect
robust
inflammatori
respons
bystand
cell
would
studi
bystand
cell
critic
understand
hypercytokinemia
influenc
immunopatholog
diseas
outcom
infect
cell
would
expos
microenviron
antivir
inflammatori
cell
death
solubl
mediat
produc
inhibit
kill
nearbi
infect
cell
howev
contrast
infect
cell
express
viral
protein
uninfect
bystand
cell
contain
antagonist
yet
expos
similarli
high
concentr
cytokin
chemokin
activ
cell
death
thu
reason
hypothes
portion
respiratori
epitheli
cell
necrosi
associ
influenza
viru
infect
may
result
immun
respons
mediat
bystand
cell
death
studi
design
address
issu
provid
import
insight
pathogenesi
cytokin
respons
may
contribut
diseas
sever
moreov
character
host
respons
pathway
respons
loss
bystand
cell
new
treatment
modal
reduc
damag
reactiv
oxygen
speci
produc
neutrophil
macrophag
could
develop
follow
section
applic
microarray
analysi
studi
regul
type
ifn
inflammatori
respons
primari
ebola
marburg
viru
infect
vitro
cultur
human
liver
cell
ex
vivo
peripher
blood
mononuclear
cell
pbmc
isol
infect
macaqu
discuss
studi
reveal
inhibit
type
ifn
stimul
gene
express
primari
infect
cell
signific
activ
inflammatori
ifn
respons
peripher
blood
infect
host
interrel
like
import
compon
extrem
human
virul
virus
ebolaviru
ebov
marburgviru
marv
member
filovirida
famili
nonseg
negativestrand
rna
virus
among
deadli
human
pathogen
gonzalez
et
al
hoenen
et
al
mohamadzadeh
et
al
human
filoviru
infect
associ
high
viremia
increas
endotheli
cell
permeabl
sever
tissu
destruct
lymphopenia
coagulopathi
ebov
marv
caus
sever
diseas
viral
hemorrhag
fever
human
nonhuman
primat
diseas
outbreak
caus
zair
ebov
zebov
subtyp
marv
case
fatal
rate
high
contrast
reston
ebov
rebov
associ
diseas
human
lethal
nonhuman
primat
groseth
et
al
hutchinson
et
al
jahrl
et
al
morikawa
et
al
observ
rais
import
question
regard
virul
filovirus
evok
similar
respons
human
cell
abil
ebov
marv
caus
sever
diseas
appear
associ
capac
replic
high
titer
evas
type
ifn
respons
common
featur
host
respons
rebov
differ
signific
way
might
explain
attenu
human
given
abil
character
global
host
respons
infect
express
microarray
function
genom
use
address
question
ifn
respons
antagon
virulenceon
hypothesi
extrem
virul
ebov
marv
viru
human
high
system
replic
rate
achiev
potent
antagon
global
antivir
respons
particularli
type
ifn
respons
test
hypothesi
gene
express
respons
cultur
human
liver
cell
infect
zebov
marv
compar
mockinfect
cell
presenc
absenc
exogen
type
ifn
kash
et
al
absenc
exogen
ifn
bioinformat
analysi
show
mani
similar
express
antivir
proinflammatori
coagul
acut
phase
relat
respons
zebov
marv
infect
significantli
examin
express
antivir
respons
gene
infect
presenc
exogen
reveal
zebov
marv
strongli
antagon
ifn
respons
two
virus
zebov
potent
inhibitor
type
ifn
receptor
respons
block
activ
approxim
nearli
gene
induc
treatment
mockinfect
cell
marv
abl
inhibit
approxim
gene
result
show
regul
host
respons
particular
antagon
type
ifn
respons
fundament
properti
virus
like
contribut
abil
caus
sever
acut
diseas
human
contrast
ident
studi
use
rebov
uncov
signific
differ
express
antivir
cellular
defens
responserel
gene
compar
zebov
reveal
rebov
significantli
less
effici
control
host
respons
human
cell
kash
et
al
dramat
rebovinfect
cell
treat
still
express
major
gene
observ
treat
mockinfect
cell
includ
increas
express
mani
mhc
class
mrna
includ
hlac
hlaa
hlab
experi
show
rebov
greatli
reduc
abil
inhibit
activ
antivir
respons
human
cell
notabl
type
ifn
respons
result
put
forth
molecular
basi
hypothesi
rebov
might
significantli
attenu
human
due
reduc
ifn
respons
antagon
lead
slower
replic
rate
increas
express
antigen
present
gene
protein
zebov
shown
import
antagonist
ifn
relat
respons
basler
et
al
addit
function
cofactor
viral
polymeras
inhibit
activ
sever
key
earli
antivir
respons
protein
includ
pkr
basler
et
al
hartman
et
al
hartman
et
al
mutat
key
residu
carboxyterminu
subsequ
found
abolish
inhibitori
activ
hartman
et
al
extent
antagon
type
ifn
respons
recent
explor
use
express
microarray
hartman
et
al
studi
hartman
et
al
show
infect
cell
cultur
recombin
zebov
express
mutant
protein
result
robust
express
mani
isg
includ
rigi
oa
observ
wildtyp
zebov
thu
singl
mutat
zebov
could
abolish
global
suppress
antivir
respons
observ
wildtyp
ebola
viru
infect
cell
cultur
howev
import
limit
studi
perform
cell
cultur
could
address
question
control
evas
host
ifn
respons
primari
infect
artifici
environ
could
describ
true
host
environ
infect
context
intact
immun
respons
experi
would
requir
studi
infect
anim
model
rubin
et
al
experi
show
mark
express
mani
inflammatori
gene
includ
apoptosi
relat
gene
includ
tnf
trail
innat
immun
respons
gene
includ
pbmc
infect
cynomolgu
macaqu
also
earli
robust
express
mani
type
ifn
regul
gene
includ
interestingli
express
ifnregul
gene
persist
throughout
cours
infect
death
author
conclud
zebov
ifn
antagonist
act
influenc
antivir
state
infect
cell
rather
inhibit
system
ifn
respons
thu
antivir
activ
ebov
ifn
antagonist
limit
infect
cell
therefor
uninfect
bystand
cell
would
still
capabl
respond
high
circul
concentr
ifn
inflammatori
cell
death
mediat
function
genom
studi
shown
robust
activ
type
ifn
antivir
inflammatori
respons
appear
affect
viral
replic
case
macaqu
experi
protect
host
lethal
effect
ebov
infect
local
activ
ifn
antagonist
infect
cell
studi
rais
question
whether
signific
activ
immun
respons
might
contribut
cell
death
sever
patholog
associ
ebov
marb
infect
howev
studi
influenza
viru
intact
anim
tissu
direct
relationship
gene
express
infect
cell
mixtur
cell
type
infect
statu
discrimin
analog
discuss
reduc
cellular
complex
influenza
viru
infect
understand
ebov
infect
modul
gene
express
program
distinct
cell
peripher
blood
requir
separ
analysi
individu
cell
type
studi
describ
review
highlight
use
genom
technolog
ad
understand
extent
alter
antivir
type
ifn
inflammatori
respons
highli
virul
rna
viru
infect
howev
studi
left
mani
persist
question
role
aberr
activ
host
respons
play
virul
pathogenesi
unansw
exagger
host
immun
respons
protect
host
consequ
high
concentr
immun
mediat
cell
neighbor
infect
cell
contribut
bystand
cell
respons
stress
cytokin
microenviron
common
inflammatori
pathway
respons
immunopatholog
relationship
inhibit
antivir
ifn
respons
infect
cell
organism
activ
ifn
respons
extent
type
interferon
immun
respons
microarray
profil
virusinfect
cell
tissu
instrument
reveal
complex
charact
ifn
respons
de
veer
et
al
studi
shown
type
ifn
signal
regul
express
hundr
gene
collect
establish
intracellular
antivir
state
function
vast
major
gene
remain
unknown
sen
sarkar
also
like
individu
isg
differ
antivir
activ
differ
famili
virus
thu
character
type
ifn
respons
gene
pathway
critic
understand
broadrang
effect
key
famili
antivir
cytokin
highthroughput
discoverybas
natur
function
genom
experi
effect
elucid
full
repertoir
antivir
infect
respons
gene
indentifi
new
host
respons
unfortun
rapid
advanc
pathwaydirect
analysi
tool
investig
genom
data
infect
model
limit
gene
known
ident
andor
function
mani
publish
studi
gene
unknown
function
limit
annot
describ
discuss
thu
one
underutil
asset
microarray
studi
use
avenu
increas
understand
host
respons
acut
infect
discov
new
gene
pathway
exampl
shown
fig
publish
studi
influenza
viru
infect
mice
reveal
approxim
gene
sequenc
unknown
unannot
function
upor
downregul
kash
et
al
moreov
mani
gene
regul
viru
infect
infect
suggest
associ
aberr
activ
inflammatori
respons
immunopatholog
similarli
function
genom
identifi
novel
member
know
antivir
pathway
includ
type
ifn
respons
shown
fig
exampl
taken
publish
studi
type
ifn
treatment
absenc
presenc
ebola
marburg
viru
infect
reveal
mani
mrna
unannot
unknown
ident
function
whose
abund
increas
upon
type
ifn
stimul
kash
et
al
moreov
ifninduc
express
major
gene
inhibit
zebov
marv
rebov
infect
human
cell
suggest
gene
could
associ
human
virul
virus
exampl
demonstr
mani
immun
regul
gene
pathway
remain
identifi
character
microarray
use
method
uncov
new
featur
fulmin
rna
viral
infect
analysi
microarray
data
presenc
absenc
drug
indic
rang
gene
express
program
affect
treatment
help
determin
efficaci
exampl
numer
microarray
studi
perform
examin
respons
patient
hepat
c
viru
therapi
interferon
ribavirin
walter
katz
howev
one
major
ratelimit
step
develop
new
host
immun
respons
target
drug
design
identif
new
moleculespathway
whose
activ
reduc
diseas
modul
therapeut
intervent
deleteri
side
effect
high
throughput
natur
express
microarray
allow
identif
hundr
thousand
infect
respons
gene
number
chang
daunt
especi
view
potenti
drug
target
howev
microarray
studi
use
refin
select
target
studi
screen
primari
secondari
gene
express
chang
affect
treatment
simpl
experiment
design
monitor
chang
gene
express
drug
treatment
help
determin
drug
exert
downstream
effect
exampl
cao
et
al
use
microarray
analysi
show
inhibit
mammalian
target
rapamycin
mtor
pathway
immunosuppress
drug
rapamycin
suppress
express
ifn
immun
respons
gene
plasmacytoid
dendrit
cell
cao
et
al
microarray
analysi
also
use
examin
molecular
effect
known
antiretrovir
drug
therapi
pacenti
et
al
wu
et
al
tradit
medicin
panhammarstrom
et
al
flexibl
global
gene
express
analysi
appli
monitor
potenti
toxic
drug
mendrick
nuwaysir
et
al
vaccin
candid
mizukami
et
al
adjuv
mosca
et
al
discoveri
driven
approach
function
genom
unravel
complex
dynam
rang
respons
associ
specif
host
respons
genespathway
delin
gene
express
respons
infect
genet
modifi
gene
knockout
ko
anim
exampl
effect
pathogenesi
host
gene
express
respons
influenza
viru
mice
lack
express
key
antivir
respons
pathway
type
ifn
inflammatori
respons
receptor
thought
associ
develop
immunopatholog
loss
singl
cytokin
chemokin
receptor
affect
host
respons
redund
altern
activ
pathway
type
iii
ifn
stimul
isg
microarray
analysi
knockout
model
employ
identifi
differ
molecular
mechan
host
respons
antagon
evas
relat
pathogen
complementari
genomewid
approach
identifi
host
pathway
import
viral
infect
new
potenti
target
antivir
therapi
use
rnai
librari
screen
host
protein
aid
viral
replic
approach
recent
use
kawaoka
colleagu
identifi
cellular
compon
necessari
replic
influenza
viru
hao
et
al
studi
especi
combin
highthroughput
discoveri
driven
natur
function
genom
studi
provid
import
new
insight
open
new
area
research
character
hostpathogen
dynam
identif
new
host
antivir
target
develop
novel
therapi
understand
molecular
mechan
virul
pathogenesi
critic
develop
new
antivir
therapi
articl
shown
global
gene
express
studi
use
detail
global
relationship
antagon
host
antivir
respons
sever
fulmin
rna
viral
infect
select
tissu
sampl
consider
develop
better
character
activ
inflammatori
cascad
develop
sever
patholog
import
immun
cell
activ
kill
immunpopatholog
becom
promin
isol
infect
andor
immun
cell
infect
tissu
blood
sampl
use
fac
lcm
method
isol
specif
cell
popul
genom
analysi
becom
wide
use
discoverybas
genom
approach
aid
identifi
host
respons
pathway
associ
immunopatholog
contribut
detail
understand
global
host
respons
regul
viral
infect
critic
develop
novel
antivir
treatment
thu
import
goal
develop
new
antivir
therapi
develop
multitarget
approach
inhibit
viral
enzymat
activ
limit
activ
deleteri
immun
respons
associ
develop
immunopatholog
may
seem
counterintuit
block
host
respons
infect
limit
temporari
inhibit
host
inflammatori
respons
could
provid
addit
protect
develop
sever
diseas
patholog
improv
clinic
outcom
strength
genomicsbas
approach
lie
abil
character
global
effect
infect
serv
discoverybas
tool
identifi
new
host
respons
compon
pathway
studi
may
ultim
lead
novel
target
therapeut
intervent
gene
express
profil
lung
mice
infect
equival
dose
reconstruct
viru
chimer
viru
express
either
ha
na
gene
ha
na
np
ns
gene
compar
contemporari
human
adapt
influenza
viru
top
panel
express
inflammatori
cytokin
gene
bottom
panel
express
type
ifn
regul
gene
infect
point
data
present
errorweight
averag
express
chang
calcul
four
technic
replic
array
perform
three
individu
mice
total
gene
shown
red
upregul
gene
shown
green
downregul
infect
rel
mockinfect
mous
lung
right
shown
lung
patholog
day
postinfect
modifi
kash
et
al
natur
data
avail
http
viromicswashingtonedupublicationshtml
gene
express
profil
bronchu
tissu
isol
macaqu
infect
equival
dose
reconstruct
viru
compar
human
adapt
influenza
viru
infect
point
data
present
errorweight
averag
express
chang
calcul
four
technic
replic
array
perform
individu
macaqu
total
gene
shown
red
upregul
gene
shown
green
downregul
infect
rel
mockinfect
macaqu
lung
modifi
kobasa
et
al
natur
data
avail
http
viromicswashingtonedupublicationshtml
express
unannot
gene
lung
tissu
isol
mice
infect
equival
dose
reconstruct
viru
compar
human
adapt
influenza
viru
infect
point
data
present
errorweight
averag
express
chang
calcul
four
technic
replic
array
perform
individu
mice
total
adapt
kash
et
al
natur
data
avail
http
viromicswashingtonedupublicationshtml
express
unannot
gene
mock
zair
ebolaviru
zebov
marburviru
marv
reston
ebolaviru
rebov
infect
cell
treat
infect
time
point
data
present
averag
express
four
technic
replic
array
perform
pool
rna
two
independ
experi
total
adapt
kash
et
al
j
virol
data
avail
http
viromicswashingtonedupublicationshtml
